Skip to main content
Top
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis

Authors: Cherry L Estilo, Pornchai O-charoenrat, Simon Talbot, Nicholas D Socci, Diane L Carlson, Ronald Ghossein, Tijaana Williams, Yoshihiro Yonekawa, Yegnanarayana Ramanathan, Jay O Boyle, Dennis H Kraus, Snehal Patel, Ashok R Shaha, Richard J Wong, Joseph M Huryn, Jatin P Shah, Bhuvanesh Singh

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

The present study is aimed at identifying potential candidate genes as prognostic markers in human oral tongue squamous cell carcinoma (SCC) by large scale gene expression profiling.

Methods

The gene expression profile of patients (n=37) with oral tongue SCC were analyzed using Affymetrix HG_U95Av2 high-density oligonucleotide arrays. Patients (n=20) from which there were available tumor and matched normal mucosa were grouped into stage (early vs. late) and nodal disease (node positive vs. node negative) subgroups and genes differentially expressed in tumor vs. normal and between the subgroups were identified. Three genes, GLUT3, HSAL2, and PACE4, were selected for their potential biological significance in a larger cohort of 49 patients via quantitative real-time RT-PCR.

Results

Hierarchical clustering analyses failed to show significant segregation of patients. In patients (n=20) with available tumor and matched normal mucosa, 77 genes were found to be differentially expressed (P< 0.05) in the tongue tumor samples compared to their matched normal controls. Among the 45 over-expressed genes, MMP-1 encoding interstitial collagenase showed the highest level of increase (average: 34.18 folds). Using the criterion of two-fold or greater as overexpression, 30.6%, 24.5% and 26.5% of patients showed high levels of GLUT3, HSAL2 and PACE4, respectively. Univariate analyses demonstrated that GLUT3 over-expression correlated with depth of invasion (P<0.0001), tumor size (P=0.024), pathological stage (P=0.009) and recurrence (P=0.038). HSAL2 was positively associated with depth of invasion (P=0.015) and advanced T stage (P=0.047). In survival studies, only GLUT3 showed a prognostic value with disease-free (P=0.049), relapse-free (P=0.002) and overall survival (P=0.003). PACE4mRNA expression failed to show correlation with any of the relevant parameters.

Conclusion

The characterization of genes identified to be significant predictors of prognosis by oligonucleotide microarray and further validation by real-time RT-PCR offers a powerful strategy for identification of novel targets for prognostication and treatment of oral tongue carcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Murray T, Xu J, Smnigal C, Thun MJ: Cancer Statistics 2006. CA Cancer J Clin. 2006, 56: 106-130. 10.3322/canjclin.56.2.106.CrossRefPubMed Jemal A, Siegel R, Ward E, Murray T, Xu J, Smnigal C, Thun MJ: Cancer Statistics 2006. CA Cancer J Clin. 2006, 56: 106-130. 10.3322/canjclin.56.2.106.CrossRefPubMed
2.
go back to reference DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 1996, 14: 367-370.CrossRef DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 1996, 14: 367-370.CrossRef
3.
go back to reference Moch H, Schraml , Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Path. 1999, 154: 981-986.CrossRefPubMedPubMedCentral Moch H, Schraml , Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Path. 1999, 154: 981-986.CrossRefPubMedPubMedCentral
4.
go back to reference Sallinen S-L, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi O-P, Kononen J: Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Research. 2000, 60: 6617-6622.PubMed Sallinen S-L, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi O-P, Kononen J: Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Research. 2000, 60: 6617-6622.PubMed
5.
go back to reference Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, Gallagher GT, Varvares M, Cohen D, Kim D, Kent R, Donoff RB, Todd R, Yung CM, Warrington JA, Wong DT: Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 2001, 20: 6196-6204. 10.1038/sj.onc.1204685.CrossRefPubMed Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, Gallagher GT, Varvares M, Cohen D, Kim D, Kent R, Donoff RB, Todd R, Yung CM, Warrington JA, Wong DT: Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 2001, 20: 6196-6204. 10.1038/sj.onc.1204685.CrossRefPubMed
6.
go back to reference Belbin TJ, Singh B, Barber I, et al: Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res. 2002, 62: 1184-1190.PubMed Belbin TJ, Singh B, Barber I, et al: Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res. 2002, 62: 1184-1190.PubMed
7.
go back to reference Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C: Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Research. 2003, 63: 1179-1182.PubMed Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C: Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Research. 2003, 63: 1179-1182.PubMed
8.
go back to reference Kuriakose MA, Chen WT, He ZM, Sikor AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, Elango EM, Delacure MD: Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci. 2004, 61: 1372-1383. 10.1007/s00018-004-4069-0.CrossRefPubMed Kuriakose MA, Chen WT, He ZM, Sikor AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, Elango EM, Delacure MD: Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci. 2004, 61: 1372-1383. 10.1007/s00018-004-4069-0.CrossRefPubMed
9.
go back to reference Mendez E, Cheng C, Farwell DG, Ricks S, Agoff SN, Futran ND, Weymuller EA, Maronian NC, Zhao LP, Chen C: Transcriptional expression profiles of oral squamous cell carcinomas. Cancer. 2002, 95: 1482-1494. 10.1002/cncr.10875.CrossRefPubMed Mendez E, Cheng C, Farwell DG, Ricks S, Agoff SN, Futran ND, Weymuller EA, Maronian NC, Zhao LP, Chen C: Transcriptional expression profiles of oral squamous cell carcinomas. Cancer. 2002, 95: 1482-1494. 10.1002/cncr.10875.CrossRefPubMed
10.
go back to reference O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B, Cheng Y, Putt M, Feldman M, Ziober B, Muschel R: Gene expression signature predicts lymphatic metastatis in squamous cell carcinoma of the oral cavity. Oncogene. 2005, 24: 1244-1251. 10.1038/sj.onc.1208285.CrossRefPubMed O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B, Cheng Y, Putt M, Feldman M, Ziober B, Muschel R: Gene expression signature predicts lymphatic metastatis in squamous cell carcinoma of the oral cavity. Oncogene. 2005, 24: 1244-1251. 10.1038/sj.onc.1208285.CrossRefPubMed
11.
go back to reference American Joint Committee on Cancer: AJCC Cancer Staging Handbook. 1998, Philadelphia: Lippincott-Raven, 5 American Joint Committee on Cancer: AJCC Cancer Staging Handbook. 1998, Philadelphia: Lippincott-Raven, 5
12.
go back to reference Schmittgen TD, Zakrajsek BA: Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophy Methods. 2000, 46: 69-81. 10.1016/S0165-022X(00)00129-9.CrossRef Schmittgen TD, Zakrajsek BA: Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophy Methods. 2000, 46: 69-81. 10.1016/S0165-022X(00)00129-9.CrossRef
13.
go back to reference Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29: 2002-2007. 10.1093/nar/29.9.e45.CrossRef Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29: 2002-2007. 10.1093/nar/29.9.e45.CrossRef
14.
go back to reference Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol. 2004, 48: 411-424. 10.1387/ijdb.041811af.CrossRefPubMed Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol. 2004, 48: 411-424. 10.1387/ijdb.041811af.CrossRefPubMed
15.
go back to reference O-charoenrat P, Rhys-Evan PH, Eccles SA: Expression of matrix metalloproteinases and their inhibitors correlate with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001, 127: 813-20.PubMed O-charoenrat P, Rhys-Evan PH, Eccles SA: Expression of matrix metalloproteinases and their inhibitors correlate with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001, 127: 813-20.PubMed
16.
go back to reference Jordan RC, Macabeo-Ong M, Shiboski CH, Dekker N, Ginzinger DG, Wong DT, Schmidt BL: Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res. 2004, 10: 6460-6465. 10.1158/1078-0432.CCR-04-0656.CrossRefPubMed Jordan RC, Macabeo-Ong M, Shiboski CH, Dekker N, Ginzinger DG, Wong DT, Schmidt BL: Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res. 2004, 10: 6460-6465. 10.1158/1078-0432.CCR-04-0656.CrossRefPubMed
17.
go back to reference Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, Ohnishi M, Ohyama T, Shingaki S, Kaji M, Saku T, Takagi R: Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer. 2003, 106: 683-689. 10.1002/ijc.11283.CrossRefPubMed Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, Ohnishi M, Ohyama T, Shingaki S, Kaji M, Saku T, Takagi R: Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer. 2003, 106: 683-689. 10.1002/ijc.11283.CrossRefPubMed
18.
go back to reference Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U: Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol. 2004, 202: 14-22. 10.1002/path.1479.CrossRefPubMed Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U: Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol. 2004, 202: 14-22. 10.1002/path.1479.CrossRefPubMed
19.
go back to reference Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA, Reed SG: Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope. 2000, 110: 374-381. 10.1097/00005537-200003000-00008.CrossRefPubMed Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA, Reed SG: Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope. 2000, 110: 374-381. 10.1097/00005537-200003000-00008.CrossRefPubMed
20.
go back to reference Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Medical Genomics. 2008, 1 (13): Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J: The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Medical Genomics. 2008, 1 (13):
21.
go back to reference Isselbacher KJ: Sugar and amino acid transport by cells in culture – differences between normal and malignant cells. N Engl J Med. 1972, 286: 929-933.CrossRefPubMed Isselbacher KJ: Sugar and amino acid transport by cells in culture – differences between normal and malignant cells. N Engl J Med. 1972, 286: 929-933.CrossRefPubMed
22.
go back to reference Holm E, Hagmuller E, Staedt U, Schlickeiser G, Gunther HJ, Leweling H, Tokus M, Kollmar HB: Substrate balances across colonic carcinomas in humans. Cancer Res. 1995, 55: 1373-1378.PubMed Holm E, Hagmuller E, Staedt U, Schlickeiser G, Gunther HJ, Leweling H, Tokus M, Kollmar HB: Substrate balances across colonic carcinomas in humans. Cancer Res. 1995, 55: 1373-1378.PubMed
23.
go back to reference Flier JS, Mueckler MM, Usher P, Lodish HF: Elevated levels of glucose transport and transporter messenger RNA are induced by ras and src oncogenes. Science. 1987, 235: 1492-1495. 10.1126/science.3103217.CrossRefPubMed Flier JS, Mueckler MM, Usher P, Lodish HF: Elevated levels of glucose transport and transporter messenger RNA are induced by ras and src oncogenes. Science. 1987, 235: 1492-1495. 10.1126/science.3103217.CrossRefPubMed
24.
go back to reference Hiraki Y, Rosen OM, Birnbaum MJ: Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem. 1988, 263: 13655-1366.PubMed Hiraki Y, Rosen OM, Birnbaum MJ: Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem. 1988, 263: 13655-1366.PubMed
25.
go back to reference Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T, Imura H: Biochem Biophys Res Commun. 1990, 170: 223-230. Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T, Imura H: Biochem Biophys Res Commun. 1990, 170: 223-230.
26.
go back to reference Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT: Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer. 1997, 80: 1046-1051. 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7.CrossRefPubMed Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT: Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer. 1997, 80: 1046-1051. 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7.CrossRefPubMed
27.
go back to reference Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J: Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res. 1997, 17: 2747-2750.PubMed Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J: Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res. 1997, 17: 2747-2750.PubMed
28.
go back to reference Mellanen P, Minn H, Grenman R, Harkonen P: Expression of glucose transporters in head and neck tumors. Int J Cancer. 1994, 56: 622-629. 10.1002/ijc.2910560503.CrossRefPubMed Mellanen P, Minn H, Grenman R, Harkonen P: Expression of glucose transporters in head and neck tumors. Int J Cancer. 1994, 56: 622-629. 10.1002/ijc.2910560503.CrossRefPubMed
29.
go back to reference Baer S, Casaubon L, Schwartz MR, Marcogliese A, Younes M: Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope. 2002, 112: 393-396. 10.1097/00005537-200202000-00034.CrossRefPubMed Baer S, Casaubon L, Schwartz MR, Marcogliese A, Younes M: Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope. 2002, 112: 393-396. 10.1097/00005537-200202000-00034.CrossRefPubMed
30.
go back to reference Kohlhase J, Hausmann S, Stojmenovic G, Dixkens C, Bink K, Schulz-Schaeffer W, Altmann M, Engel W: SALL3, a new member of the human spalt-like gene family, maps to 18q23. Genomics. 1999, 62: 212-222. 10.1006/geno.1999.6005.CrossRef Kohlhase J, Hausmann S, Stojmenovic G, Dixkens C, Bink K, Schulz-Schaeffer W, Altmann M, Engel W: SALL3, a new member of the human spalt-like gene family, maps to 18q23. Genomics. 1999, 62: 212-222. 10.1006/geno.1999.6005.CrossRef
31.
go back to reference Li D, Tian Y, Ma Y, Benjamin T: p150 (Sal2) is a p53-independent regulator of p21(WAF1/CIP). Mol Cell Biol. 2004, 24: 3885-3893. 10.1128/MCB.24.9.3885-3893.2004.CrossRefPubMedPubMedCentral Li D, Tian Y, Ma Y, Benjamin T: p150 (Sal2) is a p53-independent regulator of p21(WAF1/CIP). Mol Cell Biol. 2004, 24: 3885-3893. 10.1128/MCB.24.9.3885-3893.2004.CrossRefPubMedPubMedCentral
32.
go back to reference Bassi DE, Mahloogi H, Al-Saleem L, Lopez De Cicco R, Ridge JA, Klein-Szanto AJ: Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog. 2001, 31: 224-232. 10.1002/mc.1057.CrossRefPubMed Bassi DE, Mahloogi H, Al-Saleem L, Lopez De Cicco R, Ridge JA, Klein-Szanto AJ: Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog. 2001, 31: 224-232. 10.1002/mc.1057.CrossRefPubMed
33.
go back to reference Cheng M, Watson PH, Paterson JA, Seidah N, Chretien M, Shiu RP: Pro-protein convertase gene expression in human breast cancer. Int J Cancer. 1997, 71: 966-971. 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.0.CO;2-4.CrossRefPubMed Cheng M, Watson PH, Paterson JA, Seidah N, Chretien M, Shiu RP: Pro-protein convertase gene expression in human breast cancer. Int J Cancer. 1997, 71: 966-971. 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.0.CO;2-4.CrossRefPubMed
34.
go back to reference Mbikay M, Sirois F, Yao J, Seidah NG, Chretien M: Comparative analysis of expression of the proprotein convertase furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer. 1997, 75: 1509-1514.CrossRefPubMedPubMedCentral Mbikay M, Sirois F, Yao J, Seidah NG, Chretien M: Comparative analysis of expression of the proprotein convertase furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer. 1997, 75: 1509-1514.CrossRefPubMedPubMedCentral
35.
go back to reference Bassi DE, Lopez De Cicco R, Cenna J, Litwin S, Cukierman E, Klein-Szanto AJ: PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression. Cancer Res. 2005, 65: 7310-7319. 10.1158/0008-5472.CAN-05-1213.CrossRefPubMed Bassi DE, Lopez De Cicco R, Cenna J, Litwin S, Cukierman E, Klein-Szanto AJ: PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression. Cancer Res. 2005, 65: 7310-7319. 10.1158/0008-5472.CAN-05-1213.CrossRefPubMed
36.
go back to reference Carinci F, Lo Muzio L, Piattelli A, Rubini C, Chiesa F, Ionna F, Palmieri A, Maiorano E, Pastore A, Laino G, Favia G, Dolci M, Pezzetti : Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunol Pharm. 2005, 18: 513-524. Carinci F, Lo Muzio L, Piattelli A, Rubini C, Chiesa F, Ionna F, Palmieri A, Maiorano E, Pastore A, Laino G, Favia G, Dolci M, Pezzetti : Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunol Pharm. 2005, 18: 513-524.
37.
go back to reference Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H: Aberrant expression of RABIA in human tongue cancer. Bri J Cancer. 2005, 92: 1915-1921. 10.1038/sj.bjc.6602594.CrossRef Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H: Aberrant expression of RABIA in human tongue cancer. Bri J Cancer. 2005, 92: 1915-1921. 10.1038/sj.bjc.6602594.CrossRef
38.
go back to reference Zhou X, Temam S, Oh M, Pungpravat N, Huang B-L, Mao L, Wong DT: Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia. 2006, 8: 925-932. 10.1593/neo.06430.CrossRefPubMedPubMedCentral Zhou X, Temam S, Oh M, Pungpravat N, Huang B-L, Mao L, Wong DT: Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia. 2006, 8: 925-932. 10.1593/neo.06430.CrossRefPubMedPubMedCentral
Metadata
Title
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
Authors
Cherry L Estilo
Pornchai O-charoenrat
Simon Talbot
Nicholas D Socci
Diane L Carlson
Ronald Ghossein
Tijaana Williams
Yoshihiro Yonekawa
Yegnanarayana Ramanathan
Jay O Boyle
Dennis H Kraus
Snehal Patel
Ashok R Shaha
Richard J Wong
Joseph M Huryn
Jatin P Shah
Bhuvanesh Singh
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-11

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine